All You Need to Know About Greyledge Technologies

Our Mission

Our mission is to leverage scientific advancements in creating autologous biologic preparations, which enable physicians to optimize the practice of regenerative medicine.

Greyledge Technologies has created a technology platform that allows physicians the opportunity to integrate autologous PRP and BMCC biologic preparations into their practice. The process relies on the use of a controlled laboratory setting, coupled with a fully documented and validated sample analysis.


Our History

Greyledge Technologies was established to meet emerging physician demands to facilitate and utilize mechanisms of natural healing to augment and/or support repair of damaged tissue. Greyledge has developed novel, manual laboratory-based methods to process autologous whole blood and bone marrow tissues to produce injectable or implantable bioactive preparations. Each biologic preparation is carefully analyzed prior to return to the patient to ensure quality and to meet physician-specified  compositions. Greyledge’s approach is flexible, allowing physicians to optimize their practice of medicine through maintaining the highest standards in preparing and analyzing autologous PRP and BMCC preparations.


The Executive Team

Dr. David Karli

David C. Karli, MD MBA

Founder and Chief Executive Officer

Greyledge operations are currently being led by company Founder and CEO – David Karli. He is responsible for all aspects of company development, including the integration of a strong team of professionals to support Greyledge’s innovative approach to regenerative medicine.


Zoe Bedford Karli


Zoe Bedford Karli, our President and a Director, officially joined the Greyledge executive team in 2019.

Mark D. Kitchen

Mark D. Kitchen

VP of Operations

Mark establishes and leads many of our logistics, quality, and supporting processes as Greyledge Technologies expands its’ services throughout the United States.

howard ash

Howard Ash


Howard Ash is an accomplished Executive with extensive experience in business and finance, who served as CEO, COO, and CFO to a variety of high-profile, international companies. 


Phil Mansour


Mr. Mansour has been actively involved with disruptive technology as an inventor, manager, executive, and coach for more than 3 decades. He has extensive experience within many sectors – Bio-Technology, Consumer Electronics, Computer Science, Energy, Health Sciences, Hospitality, and Publishing. He has spoken often throughout his career on the future of technology and the effects of its disruption.

Commitment To Quality

An integral part of the goal of providing autologous biologic preparations for treating patients is the Greyledge commitment to Quality. As a part of its service, Greyledge provides a fully documented Quality system, which establishes a framework for producing biologic preparations that meet physician-established targets, in support of a physician’s practice of medicine.


Ready to Get Started?

Contact us today.